Supriya Sarkar, PhD, MPH

Director, Epidemiology and Real World Evidence
ViiV Healthcare
Baltimore, Maryland, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 795 - Awareness and Interest in PrEP Options Among US Cisgender Women – A National Survey

  Thursday, October 20, 2022
  3:15 PM – 3:30 PM US ET

• 1481 - Relative patient preferences for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among US men who have sex with men, 2021-2022

  Friday, October 21, 2022
  12:15 PM – 12:45 PM US ET

• 2255 - Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens

  Saturday, October 22, 2022
  12:15 PM – 12:45 PM US ET